1. Home
  2. Our Services
  3. GHK-Cu Copper Peptide Therapy in Washington, DC

GHK-Cu Copper Peptide Therapy in Washington, DC

GHK-Cu Copper Peptide

Some of the most powerful advances in regenerative skin care are actually molecules your body already produces – and has been producing since you were born. GHK-Cu is one of them.

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding peptide found in human. It plays a central role in tissue repair, collagen regulation, and hair follicle health. Problem is, your levels decline significantly with age. By your 60s, you’re making roughly a third of what you made at 20 (Aging Pathobiology and Therapeutics).

Medical Cosmetic Enhancements in Washington DC (serving Arlington, Bethesda, and the surrounding metro area) is preparing to offer GHK-Cu as part of its advanced peptide therapy program. This service is coming soon, and we’re building it the right way.

What Is GHK-Cu?

GHK-Cu is a tripeptide – three amino acids (glycine, histidine, and lysine) bonded to a copper ion. Researchers first identified it in human plasma in the early 1970s. Over five decades of research since then, scientists have expanded our understanding of what it does: skin anti-aging, wound healing, hair restoration, and reduction of chronic inflammation (Cosmetics).

Your body naturally produces GHK-Cu throughout your life. It’s particularly abundant in your blood, saliva, and other bodily fluids. Its job is regeneration and repair – encouraging your skin to build new collagen, remodel damaged tissue, and heal wounds.

The problem is the decline. Plasma GHK-Cu concentrations drop from roughly 200 ng/mL at age 20 to approximately 80 ng/mL by age 60, according to research in the Aging Pathobiology and Therapeutics journal. This decline tracks almost perfectly with visible signs of aging: skin thinning, loss of firmness, slowed wound healing, and thinning hair.

GHK-Cu is not currently FDA-approved as a standalone therapeutic drug for human use. However, it is among the 14 peptides that the HHS announced in early 2026 are expected to move from the FDA’s restricted Category 2 list back to Category 1 – meaning licensed compounding pharmacies would once again be able to legally prepare GHK-Cu under a physician’s prescription. This reclassification has not yet been finalized.

In anticipation of this regulatory shift, we are preparing to offer GHK-Cu as part of our physician-supervised peptide program. This service is currently coming soon. We will only make it available once fully compliant with updated FDA compounding guidelines and through licensed 503A or 503B pharmacies.

We will not offer GHK-Cu or any other peptide through unregulated channels, regardless of current market availability.

GHK-Cu for Hair Restoration

Hair follicles are highly active, metabolically demanding structures. GHK-Cu supports follicle health through multiple pathways: reducing follicle inflammation, promoting angiogenesis to improve blood supply, and stimulating the growth phase of the hair cycle. Some studies have reported that GHK-Cu performs comparably to Minoxidil for stimulating hair growth through a more targeted molecular mechanism (Bioactive Materials).

When available, GHK-Cu at Medical Cosmetic Enhancements will be discussed alongside our existing hair restoration and microneedling plus programs – both of which create an ideal tissue environment for peptide-based growth support.

How GHK-Cu Complements Other Aesthetic Treatments

Treatment
How GHK-Cu Adds Value

Fraxel & Fractional CO2

Enhances post-treatment healing and new collagen deposition

Microneedling Plus

Supports growth factor activity and tissue regeneration

Hair Restoration

Amplifies follicle stimulation via independent mechanism

RF Microneedling

Reduces post-procedure inflammation; supports collagen remodeling

IPL Photofacial

Extends skin tone results through tyrosinase and pigment modulation

This pairing potential makes GHK-Cu a strong anticipated addition to the treatment plans of patients already receiving Fraxel, RF microneedling and hydrofacials, or microneedling plus with PRP.

Frequently Asked Questions

GHK-Cu is among the peptides expected to return to legal compounding status under the 2026 FDA Category 1 reclassification. We are preparing to offer it once the regulatory pathway is confirmed and compliant sourcing through licensed pharmacies is established. Register your interest and we will notify you when it becomes available.

We only prescribe peptides through FDA-approved or legally compoundable pathways, dispensed by licensed 503A or 503B pharmacies with verified purity and sterility. Gray-market GHK-Cu products – even those widely available online – do not meet this standard.

GHK-Cu has an excellent safety profile developed over decades of research and widespread cosmetic use. It is a naturally occurring human peptide, and at therapeutic concentrations it is well-tolerated with no significant adverse effects reported in the published literature.

Standard topical collagen products cannot deliver intact collagen to the dermis – the molecules are too large to penetrate skin. GHK-Cu is small enough to penetrate the stratum corneum and directly stimulates fibroblasts to produce new collagen from within.

Yes. It pairs naturally with Sermorelin for GH-supported tissue repair and is anticipated to be part of broader skin or hair protocols alongside in-office procedures.

Get Notified When GHK-Cu Becomes Available

Skin that has thinned, lost firmness, or accumulated sun damage can respond to targeted biological signaling – the kind GHK-Cu is uniquely positioned to deliver.

At Medical Cosmetic Enhancements, we are committed to offering this therapy through fully compliant, physician-supervised protocols as soon as the regulatory pathway allows.

Call (202) 621-8675 or contact us online to register your interest and be the first to know when GHK-Cu therapy launches at our Washington, DC office.